Lisata Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Lisata Therapeutics

10/11/2022 22:52

* Lisata Therapeutics Inc  LSTA.OQ  reported a quarterly
adjusted
loss of $7.88​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 90 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Lisata Therapeutics Inc's reported EPS for the quarter was
a
loss of $7.88​.
    * The mean earnings estimate of analysts had risen by
about 36.8%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Lisata Therapeutics Inc shares had fallen by 23.9% this
quarter and lost 72.1% so far this year.
    * The company reported a quarterly loss of $37.38 million.
    * Wall Street's median 12-month price target for Lisata
Therapeutics Inc is $30.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:51 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.90          -7.88          Missed
 Jun. 30 2022      -1.45          -1.65          Missed
 Mar. 31 2022      -1.45          -1.05          Beat
 Dec. 31 2021      -2.17          -1.65          Beat